TIMP1 and ovarian carcinoma: Immunohistochemistry identified a concordance between high TIMP1 levels and a high rate of distant metastasis in breast cancer (52) and TIMP1, in serum of ovarian cancer patients with preoperative, is also associated with more aggressive tumor behavior (50).